{"id":"W3097818908","doi":"10.1182/blood-2020-137154","title":"Once Weekly Selinexor, Bortezomib, and Dexamethasone (SVd) Versus Twice Weekly Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma: High-Risk Cytogenetic Risk Planned Subgroup Analyses from the Phase 3 Boston Study","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary; University of Alberta","funders":"","keywords":"Bortezomib; Dexamethasone; Multiple myeloma; Medicine; Oncology; Internal medicine; Refractory (planetary science); Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002742006,0.001155973,0.00261075,0.0005147277,0.0002457481,0.0007330324,0.0006236391,0.0008102232,0.002524795],"category_scores_gemma":[0.001546187,0.0003888995,0.004230324,0.0004676335,0.0004163889,0.0004635223,0.0004866363,0.001545058,0.0003549063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006165227,"about_ca_system_score_gemma":0.0007326182,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007549501,"about_ca_topic_score_gemma":0.002557136,"domain_scores_codex":[0.9989659,0.0006146885,0.0001089533,0.0001223629,0.00007884688,0.0001092659],"domain_scores_gemma":[0.9988875,0.0003721305,0.0003066908,0.0001472868,0.00006560766,0.0002207646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9477302,0.003478472,0.009297588,0.0003765205,0.006977568,0.00004781045,0.00008539976,0.001099908,0.006145383,0.00005914611,0.0006136154,0.02408835],"study_design_scores_gemma":[0.5546727,0.3603456,0.05733712,0.0001101079,0.01787433,0.0001739946,0.0001628289,0.00272497,0.003311662,0.0006149836,0.002597975,0.00007378357],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941944,0.003716128,0.0002430401,0.0002215008,0.00009228545,0.0004745449,0.0006135205,0.00002156273,0.0004229657],"genre_scores_gemma":[0.995684,0.001168548,0.0004730332,0.000358722,0.0001555569,0.0006859037,0.0008042872,0.00001072757,0.0006592651],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002742006,"threshold_uncertainty_score":0.01450127,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08415400050837109,"score_gpt":0.356338819197198,"score_spread":0.2721848186888269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}